🚨 99% of Healthcare Firms Now Using GenAI, But Data Security Remains a Major Roadblock: Nutanix Report

July 14, 2025 | Tech & AI News | Trending Cart Picks

In a groundbreaking new report, Nutanix Inc. (NASDAQ: NTNX) revealed that 99% of healthcare organizations have already adopted Generative AI (GenAI) tools—from chatbots and clinical assistants to coding copilots and AI-driven diagnostics.

The findings come from Nutanix’s 7th annual Healthcare Enterprise Cloud Index (ECI) survey, released July 1. While the adoption rate is nothing short of astonishing, the report also highlighted serious concerns surrounding data security, integration hurdles, and IT infrastructure limitations in the healthcare sector.

🔐 Biggest Challenge? Data Protection at Scale

Despite GenAI's rapid integration, most healthcare leaders admitted their current data governance and cybersecurity frameworks are not strong enough to support GenAI at scale.

• 79% cited difficulty integrating GenAI with existing IT systems

• 65% pointed to data silos in healthcare databases

• 59% struggle with developing cloud-native applications and managing containers

🌐 Global Shift Toward Cloud & AI

Nutanix, a leader in enterprise cloud platforms, serves customers across North America, Europe, Asia Pacific, the Middle East, and Latin America. The company’s cloud solutions are increasingly being used in healthcare settings to support GenAI workloads and improve operational agility.

While NTNX stock remains a promising tech pick under $100, investors should be aware of both the opportunities and the infrastructure gaps highlighted in this report.

💡 Bonus Insight: Is There a Better AI Stock to Watch?

While Nutanix shows strong potential, some experts believe there are undervalued AI stocks with higher upside and lower risk—especially those positioned to benefit from the Trump-era tariffs and onshoring boom.